UK researchers have uncovered key cancer gene mutations that drive tumour growth, offering new insights into cancer ...

Cancer is often thought of as a single disease. Yet even tumors that arise in the same organ can follow very different ...

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From ...

Hiroshima University researchers have developed a practical framework to identify candidate pathogenic variants hidden among ...

A research team led by Purdue University's W. Andy Tao has discovered a new type of protein modification related to cellular ...

Hereditary breast cancer results from inherited mutations, primarily in BRCA1 and BRCA2, increasing lifetime cancer risk. Additional genes like TP53, PTEN, PALB2, CHEK2, and ATM also contribute to ...

Zongertinib provided substantial clinical benefit for patients with advanced or metastatic HER2-mutant advanced non-small cell lung cancer, surpassing the historical standard of care efficacy for this ...

Ovarian cancer management is challenging due to high morbidity and mortality, often from late-stage diagnoses. Advances in tumor genomics have led to targeted therapies, improving outcomes for ...

Oestrogen-induced DNA damage drives genomic instability in BRCA1 mutation cells, with dietary compounds showing protective potential.

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Menopausal hormone therapy did not elevate risk for breast cancer among women with inherited BRCA ...